Which MenB Vaccine Programme Applies to Students?
Student MenB and gonorrhoea vaccination are separate programmes with different eligibility. This guide explains who may be offered what and when to seek help.
Updated: 2026-09-23 • Published: 2026-09-23 • 4 sources cited
There are two separate UK vaccination programmes that can involve the MenB vaccine, but they have different purposes and eligibility rules. One is a time-limited offer for school leavers and first-year higher education students. The other is a targeted gonorrhoea vaccination programme delivered through specialist sexual health services. A clinician can clarify which programme applies to you.
Why are there two MenB vaccine programmes?
The overlap can be confusing because the same vaccine can appear in two different parts of UK health guidance.
The student MenB offer is designed around protection from Meningitis B. UKHSA says there is a time-limited MenB vaccination offer for school leavers and first-year university and higher education undergraduates. UKHSA says two doses are needed, and its advice is to receive both doses before term starts where possible.
Separately, there is a targeted vaccination programme intended to provide protection against gonorrhoea. GOV.UK guidance says this programme uses the meningococcal B vaccine known as 4CMenB, which is the same vaccine used in the MenB programme.
That does not make the two programmes interchangeable. They have different purposes and different eligibility criteria.
The gonorrhoea programme is delivered through specialist sexual health services and is offered mainly to gay, bisexual and other men who have sex with men who are considered at high risk, including people with a recent history of multiple sexual partners or a sexually transmitted infection.
If you appear to fall into more than one eligibility group, a sexual health service, GP or other appropriate clinician can explain what is recommended for you personally.
Who is eligible for the student MenB offer?
UKHSA says the time-limited MenB offer is for school leavers and first-year university and higher education undergraduates.
The timing is particularly relevant at the start of the university year. UKHSA advises eligible students to receive both required doses before term starts where possible. Dr Shamez Ladhani, a UKHSA consultant epidemiologist, has said that two doses are essential for the best protection against most strains of Meningitis B.
The public-health concern behind the programme is clear. UKHSA reported that MenB caused 97 per cent of invasive meningococcal disease among people aged 15 to 24 during 2025 to 2026, accounting for 93 of 96 cases in that age group.
UKHSA also says university students face around seven times the risk experienced by peers who do not go to university.
This offer should not be confused with MenACWY vaccination. UKHSA says MenACWY is routinely offered to teenagers and that people remain eligible for it until the age of 25.
If you are unsure whether you have already received MenB, MenACWY or both, avoid trying to work it out from memory alone. A GP, vaccination service or other clinician can help check your record and advise on the appropriate next step.
Who is offered the gonorrhoea vaccine programme?
The gonorrhoea vaccination programme is separate from the student MenB programme.
GOV.UK guidance says it is delivered through specialist sexual health services and is offered mainly to gay, bisexual and other men who have sex with men who are considered at high risk. Examples in the official guidance include people with a recent history of multiple sexual partners or a sexually transmitted infection.
The programme uses 4CMenB, the same vaccine used for MenB vaccination. That shared vaccine is the main reason the two programmes can sound like the same thing when they are not.
Eligibility for one programme does not automatically tell you whether you are eligible for the other. A student could have questions about both programmes, but the reason for offering vaccination, the service delivering it and the eligibility criteria are different.
UKHSA's provisional sexually transmitted infection data also provides some context for the separate gonorrhoea programme. UKHSA reported 13,529 gonorrhoea diagnoses at sexual health services in England in the first quarter of 2026, down from 15,942 in the previous quarter.
If you think the gonorrhoea programme may apply to you, a specialist sexual health service can assess eligibility and discuss vaccination without requiring you to make that judgement yourself.
Why do two MenB doses matter for students?
UKHSA states that the student MenB offer requires two doses. Its advice is to receive both doses before term starts where possible.
Dr Shamez Ladhani of UKHSA has said that receiving both doses is essential for the best protection against most strains of Meningitis B. Dame Diana Johnson, Minister of State, has also encouraged eligible people who have not yet come forward to do so and to receive both doses.
That means starting the course should not be treated as equivalent to completing it. If you have received one dose but are uncertain about the second, contact the service responsible for your vaccination or speak to a GP or clinician for individual advice.
UKHSA reported that 246,089 MenB vaccine doses had been given by 31 August 2026 under the offer.
Vaccination history can become especially confusing when someone has previously received other meningococcal vaccines, or may also be eligible for the separate gonorrhoea programme using 4CMenB. Rather than trying to calculate what is needed yourself, ask a clinician to review your vaccination history and current eligibility.
What should students know about meningitis symptoms?
Vaccination is important, but UKHSA also advises people to seek immediate medical attention if symptoms of meningococcal disease appear.
UKHSA lists high temperature, cold hands and feet, vomiting, confusion, rapid breathing, muscle or joint pain, pale or blotchy skin, a rash, headache, stiff neck, sensitivity to light, extreme drowsiness and seizures among the symptoms to be aware of.
These symptoms should not be used to diagnose yourself or somebody else. Different illnesses can cause similar symptoms, and a clinician needs to assess an individual situation.
The important practical message is not to delay seeking help while trying to decide what a symptom means. If you or someone you are with develops concerning symptoms from the UKHSA list, seek urgent medical advice rather than relying on online information.
UKHSA reported 348 confirmed cases of invasive meningococcal disease overall, including 26 deaths. UKHSA also reported an outbreak in Kent involving 21 cases and three deaths, alongside outbreaks in Dorset and Berkshire that each involved at least three cases.
Common Misconceptions & Clinical Facts
"The student MenB vaccine and the gonorrhoea vaccine are two different vaccines."
They use the same vaccine. GOV.UK guidance describes the gonorrhoea programme as using the meningococcal B vaccine known as 4CMenB, the same vaccine used in the MenB programme. What differs is the programme, its purpose and who is eligible.
"One MenB dose is enough for a student."
UKHSA says two doses are needed. Dr Shamez Ladhani, a UKHSA consultant epidemiologist, has said two doses are essential for the best protection against most strains of Meningitis B.
"Meningitis symptoms always start with a rash."
A rash is only one of the signs UKHSA lists. Its list also includes a high temperature, cold hands and feet, vomiting, confusion, rapid breathing, muscle or joint pain, pale or blotchy skin, headache, a stiff neck, sensitivity to light, extreme drowsiness and seizures. Waiting for a rash is not safe.
Practical context and next steps
For a student moving into university or higher education, the simplest approach is to treat the two vaccination programmes separately.
If you are a school leaver or first-year student, check whether the time-limited MenB offer applies to you and whether you have completed both required doses. A GP, vaccination service or clinician can help if your records or eligibility are unclear.
If you think the targeted gonorrhoea vaccination programme may be relevant, contact a specialist sexual health service. Eligibility is based on the programme's own criteria rather than simply on being a student.
It is also sensible to check your MenACWY status. UKHSA says this vaccine is routinely offered to teenagers and that eligibility continues until the age of 25.
Keep any vaccination records you have, but do not worry if you cannot immediately make sense of them. The names of vaccines and overlapping programmes can make the situation look more complicated than it is. A clinician can review what you have already received and explain what, if anything, is recommended next.
A decision checklist for this topic
Before acting on anything you read here, run through this short check.
Check whether the time-limited student MenB offer applies to you.
Find out whether you have received both required MenB doses.
Check your MenACWY vaccination record and ask a clinician if it is unclear.
Contact a specialist sexual health service if you think the gonorrhoea vaccination programme may apply to you.
Keep available vaccination records together so a clinician can review them more easily.
Seek urgent medical help the same day if symptoms listed by UKHSA appear.
When to get professional or urgent help
•Any sores, blisters, ulcers, unusual discharge, burning on urination or unexplained rash.
•A partner tells you they have tested positive for anything.
•A possible HIV exposure — PEP must be started within 72 hours.
•You are unsure whether what happened counts as a risk; a sexual health service will tell you rather than guess.
Safety note: If any of the symptoms listed by UKHSA appear, seek urgent medical help the same day. Do not wait to see whether a rash develops.
Seek urgent medical help the same day if symptoms listed by UKHSA appear, particularly high temperature, cold hands and feet, vomiting, confusion, rapid breathing, muscle or joint pain, pale or blotchy skin, a rash, headache, stiff neck, sensitivity to light, extreme drowsiness or seizures.
UKHSA advises immediate medical attention when these symptoms appear. Do not wait for every symptom to develop, and do not use the presence or absence of one symptom to decide what is happening.
For non-urgent questions about vaccination, contact a GP, vaccination service or specialist sexual health service. They can review your circumstances, check eligibility and explain whether you need further vaccination.
If you are worried about symptoms or somebody's condition is worsening, seek professional medical advice promptly. Individual symptoms need clinical assessment rather than online interpretation.
Questions & Clear Answers
The gonorrhoea programme uses 4CMenB, which GOV.UK guidance says is the same vaccine used in the MenB programme. However, the programmes are separate and have different purposes and eligibility criteria. If you may qualify for both, a clinician or specialist sexual health service can advise what is appropriate for your individual circumstances.
UKHSA says the time-limited MenB vaccination offer for eligible school leavers and first-year university and higher education students requires two doses. UKHSA advises receiving both before term starts where possible. If you have already had one dose or are unsure about your vaccination history, ask a GP or vaccination service for individual advice.
Not simply because they are a student. GOV.UK guidance says the targeted gonorrhoea programme is offered mainly through specialist sexual health services to gay, bisexual and other men who have sex with men who are considered at high risk. A sexual health service can assess your circumstances and explain whether you are eligible.
UKHSA advises immediate medical attention if symptoms of meningococcal disease appear. These can include fever, vomiting, confusion, rapid breathing, a rash, headache, stiff neck, sensitivity to light, extreme drowsiness and seizures. Seek urgent medical help the same day rather than trying to diagnose the cause yourself.
References & Sources
Openlywell articles are compiled with reference to published guidance from international public-health authorities, professional colleges and peer-reviewed literature.
- [1]UK Health Security Agency — Latest figures highlight ongoing Meningitis B risk for students
- [2]GOV.UK — National gonorrhoea vaccination programme using 4CMenB vaccine: frequently asked questions
- [3]UK Health Security Agency — Sexually transmitted infections quarterly report, England: provisional data, September 2026
- [4]NHS — Meningitis
Was this article helpful?
Your anonymous feedback helps our clinical and editorial team keep guides accurate and clear.
Related Guides & Further Reading
More in BlogSTI Testing: What Tests Check, When to Test and What to Expect
STI testing is not one universal test. Depending on the infection and exposure, a service may use urine, blood or swabs from the vagina, cervix, throat, rectum or another site. Testing too soon after exposure can miss some infections, so timing and repeat testing may matter.
How Do You Get Chlamydia? Symptoms, Testing, Treatment and Partner Care
Chlamydia is a common bacterial STI that is curable with appropriate antibiotics. It often causes no symptoms, so testing is important after relevant exposure or under screening recommendations. Untreated infection can cause complications, particularly in the reproductive tract.
Gonorrhoea (Gonorrhea): Symptoms, Testing, Treatment and Antibiotic Resistance
Gonorrhoea is a bacterial STI that can infect the genitals, rectum and throat. It is curable with the correct antibiotic treatment, but antimicrobial resistance is an important global problem, so treatment should follow current clinical guidance rather than old prescriptions or leftover antibiotics.